A Phase I/II Study of ATN-161 and Carboplatin in Adult Patients With Recurrent Intracranial Malignant Glioma.

Trial Profile

A Phase I/II Study of ATN-161 and Carboplatin in Adult Patients With Recurrent Intracranial Malignant Glioma.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 01 May 2012

At a glance

  • Drugs ATN 161; Carboplatin
  • Indications Anaplastic astrocytoma; Astrocytoma; Glioblastoma; Glioma; Gliosarcoma; Oligodendroglioma
  • Focus Adverse reactions; Biomarker; Therapeutic Use
  • Most Recent Events

    • 01 May 2012 Last checked against ClinicalTrials.gov record.
    • 01 May 2012 Last checked against ClinicalTrials.gov record.
    • 14 Mar 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top